Could high TSH indicate hypothyroidism?

Yes, high TSH typically indicates hypothyroidism - when your thyroid gland is underactive, your pituitary releases more TSH to stimulate thyroid hormone production. TSH above 4-4.5 mIU/L suggests hypothyroidism, with values over 10 requiring treatment.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding the TSH-Hypothyroidism Connection

Thyroid-stimulating hormone (TSH) is your body's primary indicator of thyroid function. When TSH levels rise above normal, it's often the first sign that your thyroid gland isn't producing enough hormones - a condition known as hypothyroidism. Think of TSH as your pituitary gland's way of shouting at your thyroid to work harder.

The relationship between TSH and thyroid hormones operates like a thermostat. When thyroid hormone levels (T4 and T3) drop, your pituitary gland responds by releasing more TSH to stimulate production. This inverse relationship means that high TSH typically signals low thyroid function, while low TSH suggests an overactive thyroid.

What Are Normal TSH Levels?

For most adults, normal TSH levels range from approximately 0.4 to 4.0-4.5 mIU/L. However, these values aren't one-size-fits-all. Your optimal TSH level depends on several factors including age, sex, ethnicity, and individual physiology. Research shows that each person has their own TSH 'set point' - what's normal for you might be slightly different from population averages.

TSH levels naturally shift throughout life. Children typically have slightly higher TSH ranges than adults, while older adults often see their TSH drift higher with age. Studies show that the 97.5th percentile TSH in seniors can be 0.5-2.5 mIU/L higher than in young adults. This age-related rise appears to be a normal adaptive change rather than true hypothyroidism in many cases.

Sex and Ethnic Differences

While men and women have similar TSH reference ranges, women are significantly more likely to develop thyroid disorders. Research indicates that 5-8% of women eventually develop hypothyroidism compared to about 3% of men. Ethnicity also plays a role - studies show that Black/African-American populations tend to have lower median TSH levels compared to white populations, while Hispanic populations have slightly higher average TSH.

When High TSH Confirms Hypothyroidism

High TSH levels fall into two main categories that help determine the severity of hypothyroidism and guide treatment decisions. Understanding these distinctions is crucial for proper diagnosis and management.

Overt Hypothyroidism

Overt hypothyroidism occurs when TSH is elevated above the normal range AND free T4 levels are below normal. This combination clearly indicates that your thyroid isn't producing enough hormones despite your pituitary's efforts to stimulate it. Common symptoms include fatigue, weight gain, cold intolerance, dry skin, hair loss, constipation, and depression. Regular monitoring of your thyroid function through comprehensive testing can help catch these changes early.

Subclinical Hypothyroidism

Subclinical hypothyroidism presents with elevated TSH but normal free T4 levels. This mild form affects a significant portion of the population and represents an early stage of thyroid dysfunction. While some people have no symptoms, others may experience subtle signs like mild fatigue or slight cognitive changes. The condition progresses to overt hypothyroidism in about 2-5% of cases per year, with higher progression rates when TSH exceeds 10 mIU/L or thyroid antibodies are present.

Health Risks of Untreated High TSH

Leaving high TSH untreated can lead to serious health consequences that extend far beyond thyroid symptoms. The risks vary depending on the degree of TSH elevation and individual factors like age and existing health conditions.

Cardiovascular Impact

A meta-analysis of 35 prospective studies covering over 550,000 patients found that subclinical hypothyroidism is associated with a 33% higher risk of cardiovascular disease and a 20% higher risk of all-cause mortality. The cardiovascular effects stem partly from adverse lipid changes - hypothyroidism often causes elevated LDL cholesterol and can lead to diastolic hypertension. These risks are particularly pronounced when TSH exceeds 10 mIU/L.

Metabolic and Cognitive Effects

Hypothyroidism slows metabolism throughout your body, affecting virtually every organ system. Beyond the well-known symptoms of weight gain and fatigue, untreated high TSH can lead to insulin resistance, neurocognitive impairment, and in severe cases, myxedema coma. The metabolic slowdown also affects digestive function, often causing constipation and reduced appetite.

Pregnancy Complications

For women of childbearing age, untreated hypothyroidism poses significant risks. Even mild TSH elevations during pregnancy have been associated with miscarriage, preterm birth, preeclampsia, and impaired fetal brain development. This is why thyroid function screening is crucial for women planning pregnancy or in early pregnancy.

Common Causes of High TSH

Understanding what drives TSH elevation helps in both diagnosis and treatment planning. The most common causes include autoimmune conditions, nutritional deficiencies, and medical treatments.

  • Hashimoto's thyroiditis: The leading cause of hypothyroidism in iodine-sufficient areas, this autoimmune condition gradually destroys thyroid tissue
  • Iodine deficiency: Still a significant cause globally, though less common in areas with iodized salt
  • Thyroid surgery or radiation: Medical treatments that remove or damage thyroid tissue
  • Certain medications: Including lithium, amiodarone, and some cancer treatments
  • Pituitary disorders: Rarely, TSH elevation can result from pituitary tumors or resistance to thyroid hormone

Treatment Guidelines for High TSH

Treatment decisions for high TSH depend on the degree of elevation, symptoms, and individual risk factors. Current clinical guidelines provide clear recommendations based on extensive research.

When Treatment Is Essential

Treatment with levothyroxine (synthetic thyroid hormone) is universally recommended for overt hypothyroidism (high TSH with low T4) and for any TSH level at or above 10 mIU/L. Studies show that maintaining TSH within the normal range (0.4-4.0 mIU/L) in treated patients is associated with the best outcomes, while letting TSH remain above 10 is linked to higher rates of heart disease, fractures, and mortality.

Borderline Cases: TSH 4-10 mIU/L

For mild TSH elevations between 4-10 mIU/L, treatment is individualized. Many endocrinologists consider a trial of levothyroxine if TSH is in the 7-10 range and the patient has symptoms or positive thyroid antibodies. However, if you feel well and have no risk factors, watchful waiting with periodic monitoring may be appropriate, as mild elevations often normalize on their own - especially if thyroid antibodies are negative.

Monitoring During Treatment

Once treatment begins, TSH is rechecked about 6-8 weeks after dose changes. The goal is to titrate the dose until TSH normalizes, generally targeting the mid-normal range (1-2 mIU/L) for most patients. It's crucial to avoid both under-treatment (TSH remaining high) and over-treatment (TSH too low), as both carry health risks. Regular monitoring ensures optimal thyroid hormone levels are maintained.

Special Considerations for TSH Testing

Several factors can influence TSH levels and their interpretation, making it important to consider the full clinical picture rather than relying on a single test result.

Timing and Variability

TSH follows a circadian rhythm, typically lowest in the afternoon and highest overnight. It also shows seasonal variation, naturally rising slightly in colder months. These normal fluctuations can sometimes shift a borderline TSH just inside or outside the reference range, which is why repeat testing is often recommended before making treatment decisions.

The Role of Antibody Testing

Testing for thyroid peroxidase antibodies (TPO-Ab) helps identify autoimmune thyroid disease. Positive antibodies indicate ongoing immune attack on the thyroid and predict a higher likelihood of progression from subclinical to overt hypothyroidism. Patients with positive TPO antibodies have about a two-fold higher risk of requiring thyroid hormone treatment in the future.

Taking Action on High TSH Results

If your TSH comes back elevated, don't panic - but do take it seriously. High TSH is very treatable, and proper management can prevent complications while helping you feel your best. The key is working with healthcare providers who understand the nuances of thyroid function and can create an individualized treatment plan.

Remember that TSH is just one piece of the thyroid puzzle. Comprehensive testing that includes free T4, and when appropriate, free T3 and thyroid antibodies, provides a complete picture of your thyroid health. With proper monitoring and treatment when needed, people with hypothyroidism can maintain normal, healthy lives with TSH levels in the optimal range.

Frequently Asked Questions

Understanding TSH and hypothyroidism raises many questions. Here are answers to the most common concerns about high TSH levels and thyroid health.

Frequently Asked Questions

How can I test my TSH at home?

You can test your TSH at home with SiPhox Health's Core Health Program. This CLIA-certified program includes TSH testing along with other essential biomarkers, providing lab-quality results from the comfort of your home.

What TSH level requires treatment?

Treatment is recommended for any TSH at or above 10 mIU/L, or when TSH is elevated with low free T4 (overt hypothyroidism). For TSH between 4-10 mIU/L, treatment depends on symptoms, antibody status, and individual risk factors.

Can high TSH levels return to normal without treatment?

Yes, mild TSH elevations (4-6 mIU/L) normalize on their own in a substantial fraction of patients, especially if thyroid antibodies are negative. However, TSH above 10 rarely normalizes without treatment and typically indicates permanent thyroid dysfunction.

How often should I retest TSH if it's elevated?

If TSH is mildly elevated, retesting in 6-12 weeks is recommended to confirm the elevation. Once on treatment, TSH is checked 6-8 weeks after dose changes, then annually once stable. For untreated subclinical hypothyroidism, monitoring every 6-12 months is typical.

Does high TSH always mean I need medication?

Not always. While TSH above 10 mIU/L requires treatment, mild elevations (4-10 mIU/L) may be monitored without medication if you have no symptoms and negative antibodies. Your age, symptoms, and cardiovascular risk factors help determine if treatment is needed.

Related Articles

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details